- In May 2024, Bausch Health Companies acquired an innovative retinal imaging technology firm to enhance its diagnostic product portfolio. This strategic acquisition aims to bolster the company’s capabilities in advanced eye diagnostics and expand its offerings in retinal disease management, reinforcing its commitment to improving ophthalmic care
- In June 2024, Johnson & Johnson Vision received FDA approval for the TECNIS Synergy IOL, an intraocular lens designed to deliver continuous, high-contrast vision across all distances. This innovative lens is expected to address unmet needs in cataract surgery by providing patients with superior visual clarity and reducing dependency on glasses
- In June 2024, Alcon introduced the Vivity IOL, a cutting-edge intraocular lens offering an extended depth of focus for cataract patients. This launch represents a significant advancement in lens technology, providing patients with improved visual quality and greater independence from glasses after surgery
- In July 2023, Radius XR launched the Radius 1.0 software update for perimetric exams, enhancing diagnostic capabilities for glaucoma management. The Radius system combines medical-grade diagnostics, business management tools, and patient education into a portable platform, improving accessibility and efficiency in glaucoma care
- In May 2023, U.K.-based medtech company Acurable gained FDA approval for its innovative wireless diagnostic device designed for remote diagnosis of obstructive sleep apnea (OSA). This approval marks a significant step in advancing home-based healthcare solutions, allowing patients to receive accurate diagnoses without the need for hospital visits
